Intrommune Therapeutics
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
20 W 125th St Apt 1, New York, New York,...Phone Number
(646) 494-8432Website
www.intrommune.comRevenue
<$5 MillionIndustry
About Intrommune Therapeutics
Intrommune Therapeutics is dedicated to developing innovative treatments for food allergies, focusing on a novel drug delivery platform that incorporates therapeutic agents into functional toothpaste. This approach aims to simplify the management of food allergies by allowing patients to administer treatment conveniently while brushing their teeth. With over 33 million Americans affected by food allergies, the company seeks to provide a safe and effective long-term solution through its oral mucosal immunotherapy (OMIT) platform. Their target clients include individuals suffering from food allergies who are looking for easier and more effective management options.Explore more
SIC Code 28,283NAICS Code 32,325Show moreIntrommune Therapeutics Org Chart
Compare Similar Companies to Intrommune Therapeutics
Compare insights from companies similar to Intrommune Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Intrommune Therapeutics Tech Stack
A closer look at the technologies used by Intrommune Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Intrommune Therapeutics
Sign Up For FreeTo access detailed company insights
Intrommune Therapeutics is dedicated to developing innovative treatments for food allergies, focusing on a novel drug delivery platform that incorporates therapeutic agents into functional toothpaste. This approach aims to simplify the management of food allergies by allowing patients to administer treatment conveniently while brushing their teeth.... Read More